Pentaomix
Pentaomix

Pentaomix

DR11Ahrefs DR: 11/100. Bottom 25%. Measured by Ahrefs. Median 44.Agent41Agent Readiness: 41/100. Above median. Measured by StartupHub.ai. Median 41.Speed47Site Speed: 47/100. Bottom 25%. Measured by Google PageSpeed. Median 62.

Pentaomix develops a breakthrough biopsy imaging modality for unprecedented accuracy in pathology analysis.

2020Active5Tel Aviv, Israel

About

Pentaomix provides a solution for tumor characterization using a single pathological slide, enabling pathologists to visualize cancer by staining multiple biomarkers in one step and mapping them with a hyperspectral scanner. Their system offers AI-based decision support tools for faster diagnosis, personalized drug matching, and analysis of the tumor microenvironment, serving pathologists and medical teams. This technology helps overcome challenges like limited tissue availability and the complexity of cancer subtyping.

Key facts

At-a-glance profile data

Website
pentaomix.com
Headquarters
Tel Aviv, Israel
Founded
2020
Employees
5
Total funding
-
Business model
B2B

Tech stack

Detected on pentaomix.com, last scanned 10 Sept 2026. Run your own scan

Compliance
GDPR
Frontend
jQuery, Bootstrap
Analytics
Google Analytics 4
SEO
Yoast SEO
CMS / Builders
WordPress
Email provider
Microsoft 365
Add first review

Frequently asked

How many employees does Pentaomix have?

Pentaomix has approximately 5 people on record.